Blog - Page 22 of 5356 - QualityStocks

TuesdayApr 01, 2025 10:30 am

SolarBank Corp. (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) Secures $7.3M Deal for Camillus Solar Project

SolarBank announced the sale of a 3.26 MW Camillus Solar Project to Solar Advocate Development LLC. The project will be built on a closed landfill and provide renewable energy to local subscribers. The project was awarded $1.06M in state incentives awarded under the NY-Sun Program. This marks the eighth project SolarBank has developed for Solar Advocate since 2018, and is the latest in a series of recent solar projects and battery storage systems the company has been developing. Disseminated on behalf of SolarBank Corporation SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2), a premier developer and owner of renewable and…

TuesdayApr 01, 2025 10:30 am

QualityStocksNewsBreaks – Thumzup Media Corp. (NASDAQ: TZUP) Surpasses 800 Advertisers, Maintains 243% CAGR Amid Rapid Expansion

Thumzup (NASDAQ: TZUP), a rising AdTech player in social media branding and programmatic marketing, announced it has exceeded 800 advertisers on its platform, with expectations to cross 1,000 by mid Q2 2025. The company reported a 243% compound annual growth rate, fueled by strategic expansion into South Florida, Miami, and Greater Salt Lake City. Thumzup’s platform integrates with major social networks, including Instagram Reels and X, reaching over 535 million users monthly. To view the full press release, visit https://ibn.fm/kap77 About Thumzup® Thumzup Media Corporation is democratizing the multi-billion dollar social media branding and marketing industry. Its flagship product, the…

TuesdayApr 01, 2025 10:00 am

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Advances TPI 287 for GBM, Ends 2024 with Strong Cash Position

CNS Pharmaceuticals (NASDAQ: CNSP) a biopharmaceutical company targeting brain and CNS cancers, reported a full-year 2024 net loss of $14.9 million, down from $18.9 million in 2023, due to reduced R&D spending. Despite Berubicin missing its primary endpoint in a glioblastoma multiforme (GBM) trial, the drug demonstrated safety and comparable efficacy, guiding future analysis. The company is shifting focus to TPI 287, a candidate with orphan drug designation and prior clinical data. With $6.5 million in cash at year-end and an additional $9.9 million raised post-period, CNS expects funding to last through Q1 2026. To view the full press release,…

TuesdayApr 01, 2025 9:50 am

QualityStocksNewsBreaks – Clene Inc. (NASDAQ: CLNN) to Present at Jones Healthcare and Technology Innovation Conference on April 9

Clene (NASDAQ: CLNN), a late clinical-stage biopharmaceutical company advancing treatments for neurodegenerative diseases like ALS and MS, will present at the Jones Healthcare and Technology Innovation Conference on April 9, 2025, at 11:30 a.m. PT. The event will be held at the Venetian Resort in Las Vegas and include 1x1 investor meetings. A webcast of the presentation will be available via the events section of Clene’s website. To view the full press release, visit https://ibn.fm/16NsQ About Clene Inc. Clene (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., is a late clinical-stage biopharmaceutical company focused on improving…

TuesdayApr 01, 2025 9:45 am

The MoneyShow Masters Symposium 2025 Offers an Important Opportunity for Investment and Financial Education

The MoneyShow Masters Symposium will be held in Dallas from April 4 to 5, 2025, and it will be an exclusive event that brings together high-net-worth investors and top experts in the field of finance. This two-day symposium will provide a robust platform for investors to learn from world-renowned fundamental and technical analysts, professional traders, and global market strategists. MoneyShow has been working with traders and investors for the last 44 years, guiding and providing them with optimal resources to maximize their profits. MoneyShow hosts networking events where financial wizards help traders and investors to safeguard and strengthen their portfolios.…

TuesdayApr 01, 2025 9:40 am

QualityStocksNewsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Closes $3.9 Million Offering to Advance Immunotherapy Programs

Calidi Biotherapeutics (NYSE American: CLDI), a clinical-stage biotechnology company developing targeted immunotherapies, closed its previously announced registered direct offering and concurrent private placement with a single institutional investor, raising approximately $3.9 million in gross proceeds. The offering included 3,325,000 shares of common stock and pre-funded warrants for 2,728,000 shares, along with Series G warrants for 6,053,000 shares. Proceeds will support working capital and advance Calidi’s clinical and preclinical cancer therapy programs. To view the full press release, visit: https://ibn.fm/vL35L About Calidi Biotherapeutics Calidi Biotherapeutics specializes in proprietary technology that empowers the immune system to combat cancer. The company’s novel stem…

TuesdayApr 01, 2025 9:00 am

DGE’s 5th PRC Performance Optimization Summit in Philadelphia to Cover all Aspects of Promotional Review

The 5th PRC Performance Optimization Summit by DGE will be held in Philadelphia on April 29-30, 2025. DGE invites industry professionals to discuss compliance and the expertise needed to get the best regulatory results for advertising/promotional material. The summit is hosted by Dynamic Global Events (“DGE”), a pioneer in organizing B2B events for life science companies. DGE offers the biopharma, healthcare, and medical device industries a robust forum for discussion, education, and collaboration. Promotional review committees must be well-equipped in a rapidly evolving regulatory environment to stay abreast of the best practices for new technologies and platforms. Teams must listen…

TuesdayApr 01, 2025 9:00 am

QualityStocksNewsBreaks – Brera Holdings PLC (NASDAQ: BREA) Honors Advisory Board Member Giuseppe Rossi at Fiorentina’s Pepito Day Tribute

Brera Holdings (NASDAQ: BREA), an Ireland-based company advancing a multi-club ownership model in global football, celebrated the legacy of Advisory Board member and former Italy international Giuseppe Rossi during Fiorentina’s Pepito Day on March 22 in Florence. The tribute at Stadio Artemio Franchi featured tributes from fans, football legends, and Rossi’s former coaches, recognizing his career-defining moments and contributions to the sport. Brera’s executive team and investors attended both the match and a gala in Rossi’s honor, reflecting his ongoing influence on the company’s community-first strategy. To view the full press release, visit https://ibn.fm/kgrh3 About Brera Holdings PLC Brera Holdings…

MondayMar 31, 2025 1:50 pm

QualityStocksNewsBreaks – MoneyShow’s Virtual Expo Lineup to Unlock Profitable Strategies

MoneyShow, a leading producer of live and online financial conferences for investors, traders, and financial advisors, has announced the upcoming “Income, Growth, and Value Virtual Expo,” which is slated to take place on Apr. 29-30, 2025. “Markets have experienced increased volatility due to the announcement of sweeping tariffs, retaliatory measures from trading partners, stubborn inflation metrics, and more. However, the tumult in the markets and risk-off sentiment also presents unique and new opportunities for investors to earn higher yields and robust potential returns,” said MoneyShow’s Editor-in-Chief Mike Larson. “Our lineup of speakers includes veteran investors, highly successful traders, and renowned…

MondayMar 31, 2025 11:43 am

QualityStocksNewsBreaks – Newton Golf Company Inc. (NASDAQ: NWTG) Reports 887% Full-Year Revenue Growth and Expanded Tour Presence

Newton Golf Company (NASDAQ: NWTG), a leader in premium golf equipment innovation, reported fourth quarter revenue of $1.07 million, up 817% from the prior year, and full-year revenue of $3.45 million, marking an 887% year-over-year increase. The company also doubled its gross margin to 67% in 2024, fueled by enhanced manufacturing and an improved product mix. Newton Golf, formerly Sacks Parente Golf, highlighted global retail expansion, increased PGA TOUR Champions and LPGA Tour adoption, and a successful rebranding tied to its physics-based product innovation. With $7.65 million in cash as of Dec. 31, the company projects 14 months of runway…

Site Search

Company Search